Autopsy report · NCT03151096

Pilot Evaluation of the Effect of Riboflavin Supplementation on Blood Pressure and Possible Effect Modification by the MTHFR C677T Genotype

“The target population with available genotype traveled outside study area and study duration of 19 weeks was long for some participants.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 1 year before it stopped.
• 133 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

London School of Hygiene and Tropical Medicine

Sponsor type

University, hospital or other

Conditions

High Blood Pressure; MTHFR C677T Genotype

Interventions

Riboflavin; Placebo

Participants

133

Sites

1

Countries

The Gambia

Trials that died the same way

• Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease
  “Recruitment was stopped early due to slow enrolment of this population. With no safety concerns, the study continued normally for subjects already recruited” (58% match in meaning)
• Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease
  “difficulties recruiting this population for study population” (58% match in meaning)
• Tenodesis vs. Self-locking Tenotomy in Long Head of the Biceps Tendon Lesions: A Randomized Clinical Trial
  “The study was closed due to difficulty in recruitment of target population.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.